Morgan Stanley’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.2K | Sell |
|
|||||
|
2025
Q1 | $76.7K | Buy |
|
|||||
|
2024
Q4 | $83.8K | Sell |
|
|||||
|
2024
Q3 | $109K | Sell |
|
|||||
|
2024
Q2 | $117K | Buy |
|
|||||
|
2024
Q1 | $131K | Sell |
|
|||||
|
2023
Q4 | $297K | Buy |
|
|||||
|
2023
Q3 | $158K | Buy |
|
|||||
|
2023
Q2 | $157K | Sell |
|
|||||
|
2023
Q1 | $619K | Sell |
|
|||||
|
2022
Q4 | $3.81M | Sell |
|
|||||
|
2022
Q3 | $3.42M | Sell |
|
|||||
|
2022
Q2 | $3.15M | Buy |
|
|||||
|
2022
Q1 | $5.14M | Buy |
|
|||||
|
2021
Q4 | $5.52M | Buy |
|
|||||
|
2021
Q3 | $2.64M | Buy |
|
|||||
|
2021
Q2 | $1.11M | Buy |
|
|||||
|
2021
Q1 | $137K | Buy |
|
|||||
|
2020
Q4 | $35K | Buy |
|
|||||
|
2020
Q3 | $15K | Sell |
|
|||||
|
2020
Q2 | $23K | Buy |
|
|||||
|
2020
Q1 | $19K | Sell |
|
|||||
|
2019
Q4 | $120K | Sell |
|
|||||
|
2019
Q3 | $98K | Buy |
|
|||||
|
2019
Q2 | $101K | Buy |
|
|||||
|
2019
Q1 | $97K | Sell |
|
|||||
|
2018
Q4 | $85K | Sell |
|
|||||
|
2018
Q3 | $143K | Sell |
|
|||||
|
2018
Q2 | $219K | Sell |
|
|||||
|
2018
Q1 | $220K | Sell |
|
|||||
|
2017
Q4 | $324K | Buy |
|
|||||
|
2017
Q3 | $147K | Buy |
|
|||||
|
2017
Q2 | $98K | Sell |
|
|||||
|
2017
Q1 | $80K | Sell |
|
|||||
|
2016
Q4 | $97K | Sell |
|
|||||
|
2016
Q3 | $117K | Sell |
|
|||||
|
2016
Q2 | $321K | Buy |
|
|||||
|
2016
Q1 | $25K | Buy |
|
|||||
|
2015
Q4 | $28K | Sell |
|
|||||
|
2015
Q3 | $30K | Buy |
|
|||||
|
2015
Q2 | $26K | Buy |
|
|||||
|
2015
Q1 | $24K | Sell |
|
|||||
|
2014
Q4 | $36K | Sell |
|
|||||
|
2014
Q3 | $74K | Sell |
|
|||||
|
2014
Q2 | $129K | Sell |
|
|||||
|
2014
Q1 | $310K | Buy |
|
|||||
|
2013
Q4 | $184K | Buy |
|